시장조사 보고서 : 세계의 인체 마이크로바이옴 시장예측 2021년-2026년

■ 영문 제목 : Global Human Microbiome Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00136 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 107 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 인체 마이크로바이옴의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (소화관 휴먼 미코비옴, 비뇨 생식기 휴먼 미코비옴, 기타)와 용도별 시장규모 (치료, 진단) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 인체 마이크로바이옴 시장 점유율
- 지역별 인체 마이크로바이옴 시장규모
- 주요지역의 종류별 시장규모 (소화관 휴먼 미코비옴, 비뇨 생식기 휴먼 미코비옴, 기타)
- 주요지역의 용도별 시장규모 (치료, 진단)
- 미주의 인체 마이크로바이옴 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 인체 마이크로바이옴 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 인체 마이크로바이옴 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 인체 마이크로바이옴 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 인체 마이크로바이옴 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Human Microbiome will have significant change from previous year. By the most conservative estimates of global Human Microbiome market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 309.3 million in 2020. Over the next five years the Human Microbiome market will register a 22.5% CAGR in terms of revenue, the global market size will reach US$ 696.8 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Treatment
Diagnosis

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Microbiome Market Size 2016-2026
2.1.2 Human Microbiome Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Human Microbiome Segment by Type
2.2.1 Gastrointestinal Tract Human Micobiome
2.2.2 Gastrointestinal Tract Human Micobiome
2.2.3 Others
2.3 Human Microbiome Market Size by Type
2.3.1 Global Human Microbiome Market Size CAGR by Type
2.3.2 Global Human Microbiome Market Size Market Share by Type (2016-2021)
2.4 Human Microbiome Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.5 Human Microbiome Market Size by Application
2.5.1 Global Human Microbiome Market Size CAGR by Application
2.5.2 Global Human Microbiome Market Size Market Share by Application (2016-2021)

3 Human Microbiome Market Size by Players
3.1 Human Microbiome Market Size Market Share by Players
3.1.1 Global Human Microbiome Revenue by Players (2019-2021E)
3.1.2 Global Human Microbiome Revenue Market Share by Players (2019-2021E)
3.2 Global Human Microbiome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Human Microbiome by Regions
4.1 Human Microbiome Market Size by Regions (2016-2021)
4.2 Americas Human Microbiome Market Size Growth (2016-2021)
4.3 APAC Human Microbiome Market Size Growth (2016-2021)
4.4 Europe Human Microbiome Market Size Growth (2016-2021)
4.5 Middle East & Africa Human Microbiome Market Size Growth (2016-2021)

5 Americas
5.1 Americas Human Microbiome Market Size by Country (2016-2021)
5.2 Americas Human Microbiome Market Size by Type (2016-2021)
5.3 Americas Human Microbiome Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Human Microbiome Market Size by Region (2016-2021)
6.2 APAC Human Microbiome Market Size by Type (2016-2021)
6.3 APAC Human Microbiome Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Human Microbiome by Country (2016-2021)
7.2 Europe Human Microbiome Market Size by Type (2016-2021)
7.3 Europe Human Microbiome Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Human Microbiome by Region (2016-2021)
8.2 Middle East & Africa Human Microbiome Market Size by Type (2016-2021)
8.3 Middle East & Africa Human Microbiome Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Human Microbiome Market Forecast
10.1 Global Human Microbiome Forecast by Regions (2021-2026)
10.1.1 Global Human Microbiome Forecast by Regions (2021-2026)
10.1.2 Americas Human Microbiome Forecast
10.1.3 APAC Human Microbiome Forecast
10.1.4 Europe Human Microbiome Forecast
10.1.5 Middle East & Africa Human Microbiome Forecast
10.2 Americas Human Microbiome Forecast by Countries (2021-2026)
10.2.1 United States Human Microbiome Market Forecast
10.2.2 Canada Human Microbiome Market Forecast
10.2.3 Mexico Human Microbiome Market Forecast
10.2.4 Brazil Human Microbiome Market Forecast
10.3 APAC Human Microbiome Forecast by Region (2021-2026)
10.3.1 China Human Microbiome Market Forecast
10.3.2 Japan Human Microbiome Market Forecast
10.3.3 Korea Human Microbiome Market Forecast
10.3.4 Southeast Asia Human Microbiome Market Forecast
10.3.5 India Human Microbiome Market Forecast
10.3.6 Australia Human Microbiome Market Forecast
10.4 Europe Human Microbiome Forecast by Country (2021-2026)
10.4.1 Germany Human Microbiome Market Forecast
10.4.2 France Human Microbiome Market Forecast
10.4.3 UK Human Microbiome Market Forecast
10.4.4 Italy Human Microbiome Market Forecast
10.4.5 Russia Human Microbiome Market Forecast
10.5 Middle East & Africa Human Microbiome Forecast by Region (2021-2026)
10.5.1 Egypt Human Microbiome Market Forecast
10.5.2 South Africa Human Microbiome Market Forecast
10.5.3 Israel Human Microbiome Market Forecast
10.5.4 Turkey Human Microbiome Market Forecast
10.5.5 GCC Countries Human Microbiome Market Forecast
10.6 Global Human Microbiome Forecast by Type (2021-2026)
10.7 Global Human Microbiome Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Vedanta
11.1.1 Vedanta Company Information
11.1.2 Vedanta Human Microbiome Product Offered
11.1.3 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Vedanta Main Business Overview
11.1.5 Vedanta Latest Developments
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Information
11.2.2 Seres Therapeutics Human Microbiome Product Offered
11.2.3 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Seres Therapeutics Main Business Overview
11.2.5 Seres Therapeutics Latest Developments
11.3 Second Genome
11.3.1 Second Genome Company Information
11.3.2 Second Genome Human Microbiome Product Offered
11.3.3 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Second Genome Main Business Overview
11.3.5 Second Genome Latest Developments
11.4 Rebiotix
11.4.1 Rebiotix Company Information
11.4.2 Rebiotix Human Microbiome Product Offered
11.4.3 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Rebiotix Main Business Overview
11.4.5 Rebiotix Latest Developments
11.5 ActoGeniX
11.5.1 ActoGeniX Company Information
11.5.2 ActoGeniX Human Microbiome Product Offered
11.5.3 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 ActoGeniX Main Business Overview
11.5.5 ActoGeniX Latest Developments
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Information
11.6.2 Enterome BioScience Human Microbiome Product Offered
11.6.3 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Enterome BioScience Main Business Overview
11.6.5 Enterome BioScience Latest Developments
11.7 AvidBiotics
11.7.1 AvidBiotics Company Information
11.7.2 AvidBiotics Human Microbiome Product Offered
11.7.3 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 AvidBiotics Main Business Overview
11.7.5 AvidBiotics Latest Developments
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Information
11.8.2 4D Pharma Research Ltd Human Microbiome Product Offered
11.8.3 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 4D Pharma Research Ltd Main Business Overview
11.8.5 4D Pharma Research Ltd Latest Developments
11.9 Enterologics
11.9.1 Enterologics Company Information
11.9.2 Enterologics Human Microbiome Product Offered
11.9.3 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Enterologics Main Business Overview
11.9.5 Enterologics Latest Developments
11.10 Metabogen
11.10.1 Metabogen Company Information
11.10.2 Metabogen Human Microbiome Product Offered
11.10.3 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Metabogen Main Business Overview
11.10.5 Metabogen Latest Developments
11. Metabiomics
11.11.1 Metabiomics Company Information
11.11.2 Metabiomics Human Microbiome Product Offered
11.11.3 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Metabiomics Main Business Overview
11.11.5 Metabiomics Latest Developments
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Information
11.12.2 Ritter Pharmaceuticals Human Microbiome Product Offered
11.12.3 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Ritter Pharmaceuticals Main Business Overview
11.12.5 Ritter Pharmaceuticals Latest Developments
11.13 Osel
11.13.1 Osel Company Information
11.13.2 Osel Human Microbiome Product Offered
11.13.3 Osel Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Osel Main Business Overview
11.13.5 Osel Latest Developments
11.14 Symberix
11.14.1 Symberix Company Information
11.14.2 Symberix Human Microbiome Product Offered
11.14.3 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Symberix Main Business Overview
11.14.5 Symberix Latest Developments
11.15 Miomics
11.15.1 Miomics Company Information
11.15.2 Miomics Human Microbiome Product Offered
11.15.3 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Miomics Main Business Overview
11.15.5 Miomics Latest Developments
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Information
11.16.2 Symbiotix Biotherapies Human Microbiome Product Offered
11.16.3 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Symbiotix Biotherapies Main Business Overview
11.16.5 Symbiotix Biotherapies Latest Developments
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Information
11.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Offered
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 MicroBiome Therapeutics LLC Main Business Overview
11.17.5 MicroBiome Therapeutics LLC Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Human Microbiome Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Gastrointestinal Tract Human Micobiome
Table 3. Major Players of Urogenital Tract Human Micobiome
Table 4. Major Players of Others
Table 5. Human Microbiome Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Human Microbiome Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Human Microbiome Market Size Market Share by Type (2016-2021)
Table 8. Human Microbiome Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Human Microbiome Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Human Microbiome Market Size Market Share by Application (2016-2021)
Table 11. Global Human Microbiome Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Human Microbiome Revenue Market Share by Players (2019-2021E)
Table 13. Human Microbiome Key Players Head office and Products Offered
Table 14. Human Microbiome Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human Microbiome Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Human Microbiome Market Size Market Share by Regions 2016-2021
Table 19. Americas Human Microbiome Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Human Microbiome Market Size Market Share by Country (2016-2021)
Table 21. Americas Human Microbiome Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Human Microbiome Market Size Market Share by Type (2016-2021)
Table 23. Americas Human Microbiome Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Human Microbiome Market Size Market Share by Application (2016-2021)
Table 25. APAC Human Microbiome Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Human Microbiome Market Size Market Share by Region (2016-2021)
Table 27. APAC Human Microbiome Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Human Microbiome Market Size Market Share by Type (2016-2021)
Table 29. APAC Human Microbiome Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Human Microbiome Market Size Market Share by Application (2016-2021)
Table 31. Europe Human Microbiome Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Human Microbiome Market Size Market Share by Country (2016-2021)
Table 33. Europe Human Microbiome Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Human Microbiome Market Size Market Share by Type (2016-2021)
Table 35. Europe Human Microbiome Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Human Microbiome Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Human Microbiome Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Human Microbiome Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Human Microbiome Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Human Microbiome Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Human Microbiome Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Human Microbiome Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Human Microbiome
Table 44. Key Application and Potential Industries of Human Microbiome
Table 45. Key Challenges of Human Microbiome
Table 46. Key Trends of Human Microbiome
Table 47. Global Human Microbiome Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Human Microbiome Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Human Microbiome Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Human Microbiome Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Human Microbiome Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Human Microbiome Market Size Market Share Forecast by Application (2021-2026)
Table 53. Vedanta Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 54. Vedanta Human Microbiome Product Offered
Table 55. Vedanta Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Vedanta Main Business
Table 57. Vedanta Latest Developments
Table 58. Seres Therapeutics Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 59. Seres Therapeutics Human Microbiome Product Offered
Table 60. Seres Therapeutics Main Business
Table 61. Seres Therapeutics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Seres Therapeutics Latest Developments
Table 63. Second Genome Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 64. Second Genome Human Microbiome Product Offered
Table 65. Second Genome Main Business
Table 66. Second Genome Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Second Genome Latest Developments
Table 68. Rebiotix Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 69. Rebiotix Human Microbiome Product Offered
Table 70. Rebiotix Main Business
Table 71. Rebiotix Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Rebiotix Latest Developments
Table 73. ActoGeniX Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 74. ActoGeniX Human Microbiome Product Offered
Table 75. ActoGeniX Main Business
Table 76. ActoGeniX Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. ActoGeniX Latest Developments
Table 78. Enterome BioScience Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 79. Enterome BioScience Human Microbiome Product Offered
Table 80. Enterome BioScience Main Business
Table 81. Enterome BioScience Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Enterome BioScience Latest Developments
Table 83. AvidBiotics Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 84. AvidBiotics Human Microbiome Product Offered
Table 85. AvidBiotics Main Business
Table 86. AvidBiotics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. AvidBiotics Latest Developments
Table 88. 4D Pharma Research Ltd Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 89. 4D Pharma Research Ltd Human Microbiome Product Offered
Table 90. 4D Pharma Research Ltd Main Business
Table 91. 4D Pharma Research Ltd Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. 4D Pharma Research Ltd Latest Developments
Table 93. Enterologics Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 94. Enterologics Human Microbiome Product Offered
Table 95. Enterologics Main Business
Table 96. Enterologics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Enterologics Latest Developments
Table 98. Metabogen Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 99. Metabogen Human Microbiome Product Offered
Table 100. Metabogen Main Business
Table 101. Metabogen Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Metabogen Latest Developments
Table 103. Metabiomics Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 104. Metabiomics Human Microbiome Product Offered
Table 105. Metabiomics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Metabiomics Main Business
Table 107. Metabiomics Latest Developments
Table 108. Ritter Pharmaceuticals Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 109. Ritter Pharmaceuticals Human Microbiome Product Offered
Table 110. Ritter Pharmaceuticals Main Business
Table 111. Ritter Pharmaceuticals Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Ritter Pharmaceuticals Latest Developments
Table 113. Osel Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 114. Osel Human Microbiome Product Offered
Table 115. Osel Main Business
Table 116. Osel Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Osel Latest Developments
Table 118. Symberix Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 119. Symberix Human Microbiome Product Offered
Table 120. Symberix Main Business
Table 121. Symberix Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Symberix Latest Developments
Table 123. Miomics Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 124. Miomics Human Microbiome Product Offered
Table 125. Miomics Main Business
Table 126. Miomics Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 127. Miomics Latest Developments
Table 128. Symbiotix Biotherapies Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 129. Symbiotix Biotherapies Human Microbiome Product Offered
Table 130. Symbiotix Biotherapies Main Business
Table 131. Symbiotix Biotherapies Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 132. Symbiotix Biotherapies Latest Developments
Table 133. MicroBiome Therapeutics LLC Details, Company Type, Human Microbiome Area Served and Its Competitors
Table 134. MicroBiome Therapeutics LLC Human Microbiome Product Offered
Table 135. MicroBiome Therapeutics LLC Main Business
Table 136. MicroBiome Therapeutics LLC Human Microbiome Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 137. MicroBiome Therapeutics LLC Latest Developments
List of Figures
Figure 1. Human Microbiome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Microbiome Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Human Microbiome Market Size Market Share by Type in 2020
Figure 7. Human Microbiome in Treatment
Figure 8. Global Human Microbiome Market: Treatment (2016-2021) & ($ Millions)
Figure 9. Human Microbiome in Diagnosis
Figure 10. Global Human Microbiome Market: Diagnosis (2016-2021) & ($ Millions)
Figure 11. Global Human Microbiome Market Size Market Share by Application in 2020
Figure 12. Global Human Microbiome Revenue Market Share by Player in 2020
Figure 13. Global Human Microbiome Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Human Microbiome Market Size 2016-2021 ($ Millions)
Figure 15. APAC Human Microbiome Market Size 2016-2021 ($ Millions)
Figure 16. Europe Human Microbiome Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Human Microbiome Market Size 2016-2021 ($ Millions)
Figure 18. Americas Human Microbiome Market Size Market Share by Country in 2020
Figure 19. Americas Human Microbiome Market Size Market Share by Type in 2020
Figure 20. Americas Human Microbiome Market Size Market Share by Application in 2020
Figure 21. United States Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Human Microbiome Market Size Market Share by Regions in 2020
Figure 25. APAC Human Microbiome Market Size Market Share by Type in 2020
Figure 26. APAC Human Microbiome Market Size Market Share by Application in 2020
Figure 27. China Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Human Microbiome Market Size Market Share by Country in 2020
Figure 34. Europe Human Microbiome Market Size Market Share by Type in 2020
Figure 35. Europe Human Microbiome Market Size Market Share by Application in 2020
Figure 36. Germany Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Human Microbiome Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Human Microbiome Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Human Microbiome Market Size Market Share by Application in 2020
Figure 44. Egypt Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Human Microbiome Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 50. APAC Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 51. Europe Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 53. United States Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 54. Canada Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 57. China Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 58. Japan Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 59. Korea Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 61. India Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 62. Australia Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 63. Germany Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 64. France Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 65. UK Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 66. Italy Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 67. Russia Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 68. Spain Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 71. Israel Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Human Microbiome Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Human Microbiome Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 인체 마이크로바이옴 시장예측 2021년-2026년] (코드 : LPI-2201K00136) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 인체 마이크로바이옴 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 마이크로바이옴 치료 및 진단 시장예측 2021년-2026년
LPI-2201K02344 / LP Information / 2021년 12월 / 본 조사보고서는 마이크로바이옴 치료 및 진단의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Microbiome Therapeutics and Diagnostics will have significant change from previous year. By the most conservative estimates of global Microbiome Therapeutics and Diagnostics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX...

세계의 마이크로바이옴 치료제 시장예측 2021년-2026년
LPI-2201K02229 / LP Information / 2021년 12월 / 본 조사보고서는 마이크로바이옴 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Microbiome Therapeutics will have significant change from previous year. By the most conservative estimates of global Microbiome Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 51 million in 2020. Over...

세계의 재조합 인간 인터페론 α1b 시장예측 2021년-2026년
LPI-2201K02160 / LP Information / 2021년 12월 / 본 조사보고서는 재조합 인간 인터페론 α1b의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Recombinant Human Interferon α1b will have significant change from previous year. By the most conservative estimates of global Recombinant Human Interferon α1b market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 인간 DNA 정량화 시장예측 2021년-2026년
LPI-2201K00135 / LP Information / 2021년 12월 / 본 조사보고서는 인간 DNA 정량화의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Human DNA Quantification will have significant change from previous year. By the most conservative estimates of global Human DNA Quantification market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 인간 혈장 제품 및 유도체 시장예측 2021년-2026년
LPI-2201K00047 / LP Information / 2021년 12월 / 본 조사보고서는 인간 혈장 제품 및 유도체의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Human Plasma Products and Derivatives will have significant change from previous year. By the most conservative estimates of global Human Plasma Products and Derivatives market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 인간용 호메오파시 약물 시장예측 2021년-2026년
LPI-2201K00045 / LP Information / 2021년 12월 / 본 조사보고서는 인간용 호메오파시 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Human Homeopathic Medicines will have significant change from previous year. By the most conservative estimates of global Human Homeopathic Medicines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 인간 유두종 바이러스 (HPV) 검사 시장예측 2021년-2026년
LPI-2201K00137 / LP Information / 2021년 12월 / 본 조사보고서는 인간 유두종 바이러스 (HPV) 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Human Papillomavirus (HPV) Testing will have significant change from previous year. By the most conservative estimates of global Human Papillomavirus (HPV) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 인간 혈소판 용해물 시장예측 2021년-2026년
LPI-2201K00254 / LP Information / 2021년 12월 / 본 조사보고서는 인간 혈소판 용해물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Human Platelet Lysate will have significant change from previous year. By the most conservative estimates of global Human Platelet Lysate market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2460.3 million in...

세계의 경구 투여용 인간용 백신 시장예측 2021년-2026년
LPI-2201K00048 / LP Information / 2021년 12월 / 본 조사보고서는 경구 투여용 인간용 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Human Vaccines Administered Orally will have significant change from previous year. By the most conservative estimates of global Human Vaccines Administered Orally market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...